Menu
Recruiting NCT05938569

Computer-Assisted Hair Restoration Study Using ARTAS System

No phase Interventional Androgenic Alopecia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hair restoration.
Who it may be relevant to
Registry conditions: Androgenic Alopecia. Basic parameters: 20 years — 70 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.

Interventions

  • Device Hair restoration
    The Study Treatment will involve follicular hair unit harvest, recipient site making, and implantation.

Primary outcome measures

  • Change in Hair Density from pre to 12 months post-treatment in robotic vs manual implantation [Time frame: 1 year post-treatment]
Secondary outcome measures (1)
  • Percentage of follicles successfully harvested by Robot [Time frame: 1 year post-treatment]

Eligibility criteria

Inclusion criteria

  • Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of III-VI
  • Subject is 20 to 70 years old
  • Subject agrees to cut hair short (< 1 mm) on the scalp in the designated study areas for harvesting and implantation
  • Subject is able to understand and provide written consent
  • Subject consents to post-operative follow-up per protocol

Exclusion criteria

  • Subject has prior history of scalp reduction surgery(s) in the past six months
  • Subject has bleeding diathesis
  • Subject has active use of anti-coagulation medication
  • Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 2 centers
  • Berman Skin Institute — Los Altos
  • Le's Aesthetics — San Jose

Identifiers

NCT: NCT05938569 · CP-017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗